Close Menu

A team led by investigators at the Iowa State University and Data2Bio present a genotyping-by-sequencing method designed to pick up heterozygous SNPs and other genotyping information that may be missed by typical genotyping-by-sequencing methods. The genome reduction-based approach, known as tGBS, relies on double-digestion with two restriction enzymes and replaces double-stranded adaptor molecules with single-stranded oligonucleotides, the researchers explain.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.